Form 4: Hims & Hers PAO Sells Shares Under 10b5-1 Plan

Hims & Hers Health, Inc.'s Principal Accounting Officer, Irene Becklund, sold 8,410 shares of Class A Common Stock for $50.5 per share under a pre-arranged trading plan.

Summary

• Irene Becklund, the Principal Accounting Officer (PAO) of Hims & Hers Health, Inc., reported a sale of company stock.
• The transaction involved the disposition of 8,410 shares of Class A Common Stock.
• The shares were sold at a price of $50.5 per share on September 17, 2025.
• The total value of the shares sold amounts to $424,705.
• Following this transaction, Irene Becklund beneficially owns 1,418 shares of Class A Common Stock directly.
• The sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted on August 7, 2024.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to an officer selling a significant portion of their holdings, even though it was under a pre-planned 10b5-1 arrangement. The pre-planned nature prevents a more strongly negative score, but the reduction in personal stake is noted.

Positives

• The stock sale was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating it was scheduled in advance and not based on immediate, non-public information, which mitigates concerns about opportunistic insider selling.

Negatives

• An officer selling a significant portion of their holdings (8,410 shares sold compared to 1,418 shares remaining) could be perceived by some investors as a reduction in conviction, even if pre-planned.

Risks

• Insider selling, even under a 10b5-1 plan, can sometimes be interpreted by the market as a signal of reduced confidence in the company's near-term prospects, potentially leading to negative sentiment.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This insider transaction is a routine disclosure for publicly traded companies and does not inherently reflect broader industry trends. However, investor sentiment towards the digital health and wellness sector can influence how such insider sales are perceived.

Stakeholder Impact

• Shareholders may view the sale with caution, potentially interpreting it as a signal, despite the 10b5-1 plan. The impact is likely limited given the pre-scheduled nature of the transaction.

Key Dates

Recommendation

While an officer's sale of shares can sometimes be a negative signal, this transaction was executed under a Rule 10b5-1 trading plan adopted well in advance. This suggests the sale was for personal financial planning rather than based on new, adverse material information. Given the pre-planned nature and without additional context of broader insider selling or company-specific news, a 'hold' recommendation is appropriate, advising investors to monitor future insider activity and company performance rather than reacting solely to this single transaction.

Keywords

Hims & Hers, HIMS, Insider Trading, Form 4, Stock Sale, Irene Becklund, 10b5-1 Plan, Officer Transaction